Healthcare and Life Science
Source Genomics expands sequencing portfolio with first UK commercial service on the Element Biosciences AVITI™ System
Cambridge, UK - Source Genomics, a part of the Source BioScience Group, announces their genomic laboratory expansion by adding an Element Biosciences AVITI™ System to its fleet of sequencers. ...
SciTribe logo design
Angie Moyes writes...I worked with Dr Priya Kalia on her ‘SciTribe’ logo. Priya knew that she wanted a typewriter font and came to me to further develop the idea. Priya wanted her branding to feel more ‘together’ as her business, that offers strategic communications consulting focused o...
Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Round led by new investor Panakes, with participation from all existing investors Funding will support Phase 2a clinical proof of concept trial in cystic fibrosis for a novel first in class ENaC blocker (ETD001) and pipeline expansion Dr Rob Woodman, Partner at Panakes, appo...
EUROAPI UK switches on to renewable energy
Euroapi UK has switched on their solar farm, generating renewable energy to sustain the manufacturing facility for the next 30 years. ...
CDMO: EUROAPI completes acquisition of Biano
CDMO: EUROAPI completes acquisition of Biano Paris – November 21, 2023 – EUROAPI today announced the completion of the acquisition of BianoGMP (“Biano”), strengthening its CDMO expertise in the high-growth oligonucleotide market. This acquisition further differentiates EUROAPI’s value...
EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO)
This collaboration will ensure the continuity of API development, from route scouting to process industrialization and GMP manufacturing EUROAPI and SpiroChem to provide clients with consolidated CRO-CDMO customized solutions to accelerate API chemical development and shorten timelines,...
Impact of the EU's general pharmaceutical legislation on Europe's innovation ecosystem and biotechnology companies
EuropaBio asked Charles River Associates to research the potential impact of the proposed changes included within the EU’s General Pharmaceutical Legislation (GPL) to Europe’s innovation ecosystem, with a particular focus on its impact on the growth of emerging and small biotechnology c...
The emerging business models for digital therapeutics
This article was originally published at Med Device Online. Digital therapeutics (DTx) leverage technology to deliver evidence-based treatments for various health conditions, aiming to complement or replace traditional treatments with personalized, scalable, and cost-effective int...
Queensgate awarded funding for fourth research project with NPL
Queensgate, a brand of Prior Scientific, has won funding from Innovate UK, the UK’s innovation agency, for a fourth nanopositioning research project as part of Analysis for Innovators (A4I) program (Round 11). ...
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of lentiviral production. The ready-to-transfer system minimizes...